Xichen Lin - 04 Aug 2026 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Reporting relationship: CHIEF SCIENTIFIC OFFICER
Issuer ticker: GPCR
Reported as of: 04 Aug 2026
Net transaction value: -$194,760
SEC form: 4
Accepted by SEC: 05 Aug 2026, 16:49:34 UTC
Prior SEC filing: 15 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Xichen Lin filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Aug 2026.

Key facts

This page summarizes Xichen Lin's Form 4 filing for Structure Therapeutics Inc. (GPCR).
6 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 05 Aug 2026, 16:49.

Change

Previous filing in this sequence was filed on 15 Jul 2026.
Current net transaction value: -$194,760.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001962926 Primary reporting owner

Lin Xichen

Relationship: CHIEF SCIENTIFIC OFFICER
Address: C/O STRUCTURE THERAPEUTICS INC., 601 GATEWAY BLVD., SUITE 900, SOUTH SAN FRANCISCO
Signature: /s/ Jun Yoon, Attorney-in-Fact
Signature date: 05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GPCR transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +11,817
Change %: +5.2%
Price: $0.3400^*
Shares after: 240,777
Date: 04 Aug 2026
Ownership: Direct
Footnotes: F1

GPCR transaction

Ordinary Shares

Conversion of derivative security

Transaction value
Shares: -11,817
Change %: -4.9%
Price: $0.000000^*
Shares after: 228,960
Date: 04 Aug 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value
Shares: -11,817
Change %: -7.1%
Price: $0.000000^*
Shares after: 154,715
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 11,817
Exercise price: $0.3400
Footnotes: F1, F3, F4

GPCR transaction Derivative

American Depositary Shares

Conversion of derivative security

Transaction value
Shares: +3,939
Change %
Price: $0.000000^*
Shares after: 3,939
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 11,817
Exercise price
Footnotes: F5, F6

GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value: $152,786
Shares: -3,100
Change %: -79%
Price: $49.29
Shares after: 839
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 9,300
Exercise price
Footnotes: F5, F7, F8, F9

GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value: $41,974
Shares: -839
Change %: -100%
Price: $50.03
Shares after: 0
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,517
Exercise price
Footnotes: F5, F7, F8, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

Reflects price per share in Ordinary Shares.

Footnote F2

The Ordinary Shares were converted into American Depositary Shares as reported in Table II.

Footnote F3

1/4 of the Ordinary Shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the Ordinary Shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.

Footnote F4

This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 11,817 Ordinary Shares.

Footnote F5

Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

Footnote F6

11,817 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 3,939 American Depositary Shares.

Footnote F7

The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 26, 2026.

Footnote F8

Reflects price per share in American Depositary Shares.

Footnote F9

The weighted average sale price for the transaction reported was $49.2857 and the range of prices were between $48.66 and $49.65. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.

Footnote F10

The weighted average sale price for the transaction reported was $50.0290, and the range of prices were between $49.69 and $50.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.